Criteria for the selection and treatment of clinically localised prostate cancer.

The main objective of the prostate cancer (PC) project is to improve the understanding of prostate cancer by utilising known and newly-developed methods. In a broad collaboration between units, departments and institutes, the objective is to contribute to reducing illness and morbidity in patients with clinically localised disease.

A secondary objective of the PC project is to establish a clinical database to assist with the quality control of diagnostics, staging of prostate cancer, operation (radical prostatectomy), therapeutical side effects, life quality, time of any relapses of the disease (biochemical, radiological) and surviving prostate cancer.

All patients who undergo surgery for removal of the prostate gland (radical prostatectomy) have had the opportunity to participate in the PC project since 2002. Approx. 1,900 patients contributed to the PC biobank with blood- and urine samples as well as prostate tissue.

The PC project is being carried out in close collaboration with the Department of Molecular Medicine (MOMA) Read more here